| GFACX | HRCIX | GFACX / HRCIX | |
| Total Expense Ratio | 1.36 | 0.75 | 181% |
| Annual Report Gross Expense Ratio | 1.36 | 0.75 | 181% |
| Fund Existence | 25 years | 20 years | - |
| Gain YTD | 15.041 | 18.611 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 10000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 327B | 563M | 58,082% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 4.83 | 6.91 | 70% |
| Returns for 3 years | 55.67 | 41.15 | 135% |
| Returns for 5 years | 25.13 | 21.36 | 118% |
| Returns for 10 years | 70.54 | 71.08 | 99% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBCG | 52.81 | 0.56 | +1.07% |
| Fidelity Blue Chip Growth ETF | |||
| THIR | 31.25 | 0.07 | +0.22% |
| THOR Index Rotation ETF | |||
| SDSI | 51.60 | 0.01 | +0.01% |
| American Century® Short Dur Str Inc ETF | |||
| IBMQ | 25.51 | -0.01 | -0.04% |
| iShares iBonds Dec 2028 Term Muni Bd ETF | |||
| FTXH | 31.61 | -0.29 | -0.90% |
| First Trust Nasdaq Pharmaceuticals ETF | |||